Irvine’s Endocare Reports Loss for 1995
- Share via
IRVINE — Endocare Inc., which makes surgical devices for treating prostate disease, said it lost $577,000 for 1995, compared with a loss of $263,000 in 1994. Per-share amounts were not available. Revenue dropped by 50% to $1.3 million, because of a shift in the urology market from laser-based therapy to electro-vaporization devices.
The company said its results were as a division of Medstone International Inc. In January, Endocare became an independent company.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
